According to the pharmacologic study, Agrimonia pilosa Ledeb contains chemical components namely agrimonin, agrimol C,F,G, agrimonolide, agrimophol, apigenin-7-O- glucoside, thalictiin , coumarin, tannin, sterin and quercetin. Agrimonia pilosa has been reported to possess cytotoxic, anti-oxidant, anti-tumor, antiviral, anti-microbial, anti-inflammatory, anthelmintic, anticoagulant and antiallergic activities. Agrimonia pilosa is mainly used for treatments of bloody discharge, urinary tract infections and sexually transmitted diseases, haemorrhoid, parasitic infections and skin disorders. In the future, we suggest that we have to conduct detailed pharmacological study on chemical components and effects of Agrimonia pilosa ldb (in vitro) based on the modern medical science as well as we have got an opportunity to produce new drug that can lead to new innovation.

Determining effect of pharmaceutical preparation of Osteocalcium-5 for 50-65years old patients who diagnosed as primary osteoprosis after menopause. All 120 volunteers were divided randomly into control and clinical experiemental group also private specialty test was taken from each group as well. Control group (n60) had oral medication Citratcalcium D, clinical experiement group had oral Osteocalcium-5. After medication result of mineral density of osteoprosis , fracture risk and result of private specialty were compared. Result: 65.8% of patients who diagnosed as primary osteoprosis after menopause are concept of Badgan private specialty. After 2 months of oral medication in each group SOS measurement enhanced by 3-4%, fracture risk decreased by 39.6%. Conclution: In Traditional medical, concept of Badgan private specialty more tendency for osteoprosis. Osteocalcium-5 improves osteon of compact bone patiets with osteoprosis after menopause and decreased risk of fracture. Also result of pharmaceutical preparation of Osteocalcium -5 does not depend on private specialty but patients who are active lifestyle and stomach fire is proper had possitive effect.